IRONWOOD PHARMACEUTICALS, INC. Number of Reportable Segments
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Number of Reportable Segments of 1 segment for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:NumberOfReportableSegments · last filed 2026-08-06
- IRONWOOD PHARMACEUTICALS, INC. number of reportable segments for the quarter ending 2026-06-30 was 1.00 segment, a 0.00% change year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. number of reportable segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. number of reportable segments for the quarter ending 2025-09-30 was 1.00 segment, a 0.00% change year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. number of reportable segments for the quarter ending 2025-06-30 was 1.00 segment, a 0.00% change year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. number of reportable segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- IRONWOOD PHARMACEUTICALS, INC. number of reportable segments for fiscal 2024 was 1.00 segment, a 0.00% change from fiscal 2023.
- IRONWOOD PHARMACEUTICALS, INC. number of reportable segments for fiscal 2023 was 1.00 segment, a 0.00% change from fiscal 2022.
- IRONWOOD PHARMACEUTICALS, INC. number of reportable segments for fiscal 2022 was 1.00 segment, a 0.00% change from fiscal 2021.
| Period end | Number of Reportable Segments 0 month | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-06 | 1.00 segment 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-07 | ||||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-10 | 1.00 segment 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2026-08-06 | 1.00 segment 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2026-05-07 | ||||
| 2024-12-31 | 1.00 segment 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | 1.00 segment 10-Q · filed 2025-11-10 | 1.00 segment 10-Q · filed 2025-11-10 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2025-08-11 | 1.00 segment 10-Q · filed 2025-08-11 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2025-05-12 | ||||
| 2023-12-31 | 1.00 segment 10-K · filed 2025-03-31 | ||||
| 2022-12-31 | 1.00 segment 10-K · filed 2025-03-31 | ||||
| 2021-12-31 | 1.00 segment 10-K · filed 2024-02-16 | ||||
| 2020-12-31 | 1.00 segment 10-K · filed 2023-02-16 | ||||
| 2020-09-30 | 1.00 segment 10-Q · filed 2020-11-05 | 1.00 segment 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | 1.00 segment 10-Q · filed 2020-08-06 | 1.00 segment 10-Q · filed 2020-08-06 | |||
| 2019-12-31 | 1.00 segment 10-K · filed 2022-02-18 | ||||
| 2019-09-30 | 1.00 segment 10-Q · filed 2020-11-05 | 1.00 segment 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | 1.00 segment 10-Q · filed 2020-08-06 | 1.00 segment 10-Q · filed 2020-08-06 | |||
| 2018-12-31 | 1.00 segment 10-K · filed 2021-02-17 | ||||
| 2018-09-30 | 1.00 segment 10-Q · filed 2019-10-31 | 1.00 segment 10-Q · filed 2019-10-31 | |||
| 2018-06-30 | 1.00 segment 10-Q · filed 2019-07-30 | 1.00 segment 10-Q · filed 2019-07-30 | |||
| 2017-12-31 | 1.00 segment 10-K · filed 2018-02-22 | ||||
| 2016-12-31 | 1.00 segment 10-K · filed 2017-02-22 | ||||
| 2015-12-31 | 1.00 segment 10-K · filed 2016-02-19 | ||||
| 2014-12-31 | 1.00 segment 10-K · filed 2015-02-18 | ||||
| 2013-12-31 | 1.00 segment 10-K · filed 2014-02-07 | ||||
| 2012-12-31 | 1.00 segment 10-K · filed 2013-02-21 | ||||
| 2012-09-30 | 1.00 segment 10-Q · filed 2012-11-06 | ||||
| 2010-09-21 | 2.00 segment 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |